Overview
Claudia Haferlach practices practicing medicine in Munich, Germany.
Ms. Haferlach is highly rated in 33 conditions, according to our data. Her clinical expertise encompasses Leukemia, Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML), RUNX1 Familial Platelet Disorder, and Bone Marrow Transplant.
She is actively involved in clinical research, co-authoring 320 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Claudia Haferlach
Is Claudia Haferlach a top-rated expert for Leukemia?
MediFind is an objective health platform that identifies experts based on real-world data. Claudia Haferlach is classified as an Elite expert for Leukemia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Claudia Haferlach participate in research or clinical trials?
Yes. Claudia Haferlach has published 320 articles and abstracts on conditions like Leukemia. You can view a list of Claudia Haferlach's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Acute Myeloid Leukemia (AML)Ms. Haferlach isElite. Learn about Acute Myeloid Leukemia (AML).
- Chronic Myelogenous Leukemia (CML)
- LeukemiaMs. Haferlach isElite. Learn about Leukemia.
- Myelodysplastic Syndrome (MDS)Ms. Haferlach isElite. Learn about Myelodysplastic Syndrome (MDS).
- RUNX1 Familial Platelet DisorderMs. Haferlach isElite. Learn about RUNX1 Familial Platelet Disorder.
- Distinguished
- Acute Lymphoblastic Leukemia (ALL)Ms. Haferlach isDistinguished. Learn about Acute Lymphoblastic Leukemia (ALL).
- Chromosome 7p DeletionMs. Haferlach isDistinguished. Learn about Chromosome 7p Deletion.
- Chronic B-Cell Leukemia (CBCL)Ms. Haferlach isDistinguished. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)Ms. Haferlach isDistinguished. Learn about Chronic Lymphocytic Leukemia (CLL).
- Hairy Cell Leukemia (HCL)Ms. Haferlach isDistinguished. Learn about Hairy Cell Leukemia (HCL).
- Multiple MyelomaMs. Haferlach isDistinguished. Learn about Multiple Myeloma.
- Ring Chromosome 7Ms. Haferlach isDistinguished. Learn about Ring Chromosome 7.
- Advanced
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Promyelocytic LeukemiaMs. Haferlach isAdvanced. Learn about Acute Promyelocytic Leukemia.
- Adult T-Cell LeukemiaMs. Haferlach isAdvanced. Learn about Adult T-Cell Leukemia.
- AnemiaMs. Haferlach isAdvanced. Learn about Anemia.
- B-Cell LymphomaMs. Haferlach isAdvanced. Learn about B-Cell Lymphoma.
- Burkitt LymphomaMs. Haferlach isAdvanced. Learn about Burkitt Lymphoma.
- Chromosome 13q DuplicationMs. Haferlach isAdvanced. Learn about Chromosome 13q Duplication.
- Chronic Myelomonocytic Leukemia (CMML)Ms. Haferlach isAdvanced. Learn about Chronic Myelomonocytic Leukemia (CMML).
- Chronic T-Cell Leukemia (CTCL)Ms. Haferlach isAdvanced. Learn about Chronic T-Cell Leukemia (CTCL).
- Essential ThrombocythemiaMs. Haferlach isAdvanced. Learn about Essential Thrombocythemia.
- Mantle Cell Lymphoma (MCL)Ms. Haferlach isAdvanced. Learn about Mantle Cell Lymphoma (MCL).
- Marginal Zone Lymphoma (MZL)Ms. Haferlach isAdvanced. Learn about Marginal Zone Lymphoma (MZL).
- Mast Cell Activation Syndrome (MCAS)Ms. Haferlach isAdvanced. Learn about Mast Cell Activation Syndrome (MCAS).
- Myeloproliferative Neoplasms (MPN)Ms. Haferlach isAdvanced. Learn about Myeloproliferative Neoplasms (MPN).
- Non-Hodgkin LymphomaMs. Haferlach isAdvanced. Learn about Non-Hodgkin Lymphoma.
- Prolymphocytic LeukemiaMs. Haferlach isAdvanced. Learn about Prolymphocytic Leukemia.
- Sideroblastic AnemiaMs. Haferlach isAdvanced. Learn about Sideroblastic Anemia.
- Small Lymphocytic Lymphoma (SLL)Ms. Haferlach isAdvanced. Learn about Small Lymphocytic Lymphoma (SLL).
- Systemic MastocytosisMs. Haferlach isAdvanced. Learn about Systemic Mastocytosis.
- Trisomy 13Ms. Haferlach isAdvanced. Learn about Trisomy 13.
- Experienced
- Acute Megakaryoblastic LeukemiaMs. Haferlach isExperienced. Learn about Acute Megakaryoblastic Leukemia.
- Bone Marrow TransplantMs. Haferlach isExperienced. Learn about Bone Marrow Transplant.
- Chromosome 12p DeletionMs. Haferlach isExperienced. Learn about Chromosome 12p Deletion.
- Congenital Hemolytic AnemiaMs. Haferlach isExperienced. Learn about Congenital Hemolytic Anemia.
- Follicular LymphomaMs. Haferlach isExperienced. Learn about Follicular Lymphoma.
- HemoglobinopathyMs. Haferlach isExperienced. Learn about Hemoglobinopathy.
- Hemolytic AnemiaMs. Haferlach isExperienced. Learn about Hemolytic Anemia.
- LeukocytosisMs. Haferlach isExperienced. Learn about Leukocytosis.
- MyelofibrosisMs. Haferlach isExperienced. Learn about Myelofibrosis.
- Philadelphia-Negative Chronic Myeloid Leukemia
- Polycythemia VeraMs. Haferlach isExperienced. Learn about Polycythemia Vera.
- Relapsed Refractory Multiple Myeloma (RRMM)Ms. Haferlach isExperienced. Learn about Relapsed Refractory Multiple Myeloma (RRMM).
- SplenomegalyMs. Haferlach isExperienced. Learn about Splenomegaly.
- T-Cell LymphomaMs. Haferlach isExperienced. Learn about T-Cell Lymphoma.
- ThalassemiaMs. Haferlach isExperienced. Learn about Thalassemia.
- VEXAS SyndromeMs. Haferlach isExperienced. Learn about VEXAS Syndrome.